JP Morgan Raises Intuitive Surgical (ISRG) Price Target to $475

JP Morgan reaffirmed its Overweight rating on Intuitive Surgical, Inc. (NasdaqGS: ISRG) on October 21, 2026, and raised its price target from $450.00 to $475.00. The update arrived in a research note from the firm, highlighting confidence in the medical technology provider even as the shares trade below the newly minted target.

ISRG Intuitive Surgical, Inc.

$428.12 ▼ -23.82% year to date

1M 3M YTD

Daily close · Oct 21, 2026

JP Morgan's Call on Intuitive Surgical, Inc.

In its October 21, 2026 note, JP Morgan kept its Overweight rating on the shares and bumped its target up by $25.00 to $475.00. The firm's forward-looking view supports the company's market position in robotic-assisted surgery systems.

Intuitive Surgical, Inc. Stock Up 0.3%

The equity recently changed hands around $427.48, down about 0.7% from an event-day close of $430.46 on October 21, 2026. The stock sits below its 200-day moving average of $438.97, though it holds ground above its 50-day moving average of $392.76. Shares remain well below their 52-week high of $603.88 while staying up over 30% from their 52-week low of $328.57.

Recent Earnings

Intuitive Surgical generated trailing-twelve-month revenue of $11.03 billion, alongside an earnings per share figure of $8.85. The company operates with a trailing price-to-earnings ratio of 48.95.

Insider Buying and Selling at Intuitive Surgical, Inc.

Company insiders completed four transactions prior to the update. Officer Mark Preston Brosius sold 154 shares on August 21, 2026, for $59,439.00, followed by a sale of 69 shares on September 9, 2026, valued at $24,671.00, and 48 shares on September 11, 2026, worth $17,141.00. Additionally, officer Fredrik Widman sold 1,089 shares at $374.44 each on September 15, 2026, for a total value of $407,765.00.

Analysts Set New Price Targets

Several research firms updated their views on October 21, 2026. Leerink Partners maintained an Outperform rating and raised its target from $473.00 to $503.00. Evercore ISI Group kept an In-Line rating and lowered its target from $400.00 to $385.00. Wells Fargo maintained an Overweight rating with a target moving from $487.00 to $486.00, and TD Cowen reiterated a Buy rating with a target of $485.00. Across the broader street, 30 analysts maintain opinions, generating a consensus buy recommendation and a mean price target of $478.53.

About Intuitive Surgical, Inc.

Headquartered in Sunnyvale, California, Intuitive Surgical designs and builds robotic systems that help doctors perform minimally invasive surgical procedures. Its technology aids healthcare providers globally, making complex operations less invasive for patients.

Bottom Line

JP Morgan's higher target points to further upside potential from recent trading levels near $427.48. Investors will watch whether subsequent analyst revisions bridge the gap toward the consensus mean target of $478.53.